{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:08:06Z","timestamp":1769602086667,"version":"3.49.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["redjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.ijrobp.2016.07.027","type":"journal-article","created":{"date-parts":[[2016,7,30]],"date-time":"2016-07-30T21:05:01Z","timestamp":1469912701000},"page":"840-847","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["High-Dose Hypofractionated Radiation Therapy for Noncompressive Vertebral Metastases in Combination With Zoledronate: A Phase 1 Study"],"prefix":"10.1016","volume":"96","clinical-trial-number":[{"clinical-trial-number":"nct01219790","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Baptiste","family":"Pichon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lo\u00efc","family":"Campion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gr\u00e9gory","family":"Delpon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Thillays","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Carrie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrice","family":"Cellier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Pommier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9cile","family":"Laude","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Augustin","family":"Mervoyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadji","family":"Hamidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc-Andr\u00e9","family":"Mah\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Supiot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2016.07.027_bib1","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1302\/0301-620X.84B4.12495","article-title":"The surgical treatment of bony metastases of the spine and limbs","volume":"84-B","author":"B\u00f6hm","year":"2002","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.ijrobp.2016.07.027_bib2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3171\/SPI-07\/08\/151","article-title":"Phase I\/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure","volume":"7","author":"Chang","year":"2007","journal-title":"J Neurosurg Spine"},{"key":"10.1016\/j.ijrobp.2016.07.027_bib3","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1200\/JCO.2006.09.5281","article-title":"Palliative radiotherapy trials for bone metastases: A systematic review","volume":"25","author":"Chow","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2016.07.027_bib4","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2010.11.026","article-title":"Palliative radiotherapy for bone metastases: An ASTRO evidence-based guideline","volume":"79","author":"Lutz","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.07.027_bib5","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1002\/cncr.25918","article-title":"Prospective evaluation of spinal reirradiation by using stereotactic body radiation therapy: The University of Texas MD Anderson Cancer Center experience","volume":"117","author":"Garg","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2016.07.027_bib6","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1470-2045(11)70384-9","article-title":"Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: A phase 1-2 trial","volume":"13","author":"Wang","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2016.07.027_bib7","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1200\/JCO.2013.50.1411","article-title":"Vertebral compression fracture after spine stereotactic body radiotherapy: A multi-institutional analysis with a focus on radiation dose and the spinal instability neoplastic score","volume":"31","author":"Sahgal","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2016.07.027_bib8","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1093\/jnci\/94.19.1458","article-title":"A randomized, placebo-controlled trial of zoledronate in patients with hormone-refractory metastatic prostate carcinoma","volume":"94","author":"Saad","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2016.07.027_bib9","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/cncr.11892","article-title":"Zoledronate is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion","volume":"100","author":"Rosen","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2016.07.027_bib10","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s12094-008-0198-5","article-title":"Randomised study of single dose (8 Gy vs. 6 Gy) of analgesic radiotherapy plus zoledronate in patients with bone metastases","volume":"10","author":"Ma\u00f1as","year":"2008","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.ijrobp.2016.07.027_bib11","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ijrobp.2004.09.065","article-title":"Synergistic cytotoxic effects of zoledronate and radiation in human prostate cancer and myeloma cell lines","volume":"61","author":"Algur","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.07.027_bib12","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1158\/1078-0432.CCR-12-0489","article-title":"Novel aspects of mevalonate pathway inhibitors as antitumor agents","volume":"18","author":"Thurnher","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2016.07.027_bib13","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1182\/blood-2003-05-1655","article-title":"Induction of gammadelta T-lymphocyte effector functions by bisphosphonate zoledronate in cancer patients in\u00a0vivo","volume":"102","author":"Dieli","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2016.07.027_bib14","doi-asserted-by":"crossref","first-page":"7450","DOI":"10.1158\/0008-5472.CAN-07-0199","article-title":"Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer","volume":"67","author":"Dieli","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2016.07.027_bib15","doi-asserted-by":"crossref","first-page":"e597","DOI":"10.1016\/j.ijrobp.2012.03.009","article-title":"International Spine Radiosurgery Consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgery","volume":"83","author":"Cox","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.07.027_bib16","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.semradonc.2008.04.001","article-title":"An overview of hypofractionation and introduction to this issue of seminars in radiation oncology","volume":"18","author":"Timmerman","year":"2008","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2016.07.027_bib17","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11523-013-0280-y","article-title":"Concurrent sunitinib and stereotactic body radiotherapy for patients with oligometastases: Final report of a prospective clinical trial","volume":"9","author":"Kao","year":"2014","journal-title":"Target Oncol"},{"key":"10.1016\/j.ijrobp.2016.07.027_bib18","doi-asserted-by":"crossref","first-page":"e401","DOI":"10.1200\/JCO.2012.47.7455","article-title":"Ablation of a site of progression with stereotactic body radiation therapy extends sunitinib treatment from 14 to 22 months","volume":"31","author":"Straka","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2016.07.027_bib19","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.canrad.2014.04.005","volume":"18","author":"Pichon","year":"2014","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.ijrobp.2016.07.027_bib20","first-page":"979214","article-title":"Stereotactic body radiosurgery for spinal metastatic disease: An evidence-based review","volume":"2011","author":"Hall","year":"2011","journal-title":"Int J Surg Oncol"},{"key":"10.1016\/j.ijrobp.2016.07.027_bib21","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/jso.20949","article-title":"Concurrent administration of zoledronate and irradiation leads to improved bone density, biomechanical strength, and microarchitecture in a mouse model of tumor-induced osteolysis","volume":"97","author":"Arrington","year":"2008","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ijrobp.2016.07.027_bib22","doi-asserted-by":"crossref","first-page":"5075","DOI":"10.1200\/JCO.2008.19.3508","article-title":"Risk of fracture after single fraction image-guided intensity-modulated radiation therapy to spinal metastases","volume":"27","author":"Rose","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2016.07.027_bib23","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.ijrobp.2008.07.035","article-title":"Early clinical experience and outcome of helical tomotherapy for multiple metastatic lesions","volume":"73","author":"Lee","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.07.027_bib24","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.ijrobp.2011.08.036","article-title":"Oligometastases treated with stereotactic body radiotherapy: Long-term follow-up of prospective study","volume":"83","author":"Milano","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.07.027_bib25","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1002\/cncr.26611","article-title":"Stereotactic body radiotherapy for multisite extracranial oligometastases: Final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease","volume":"118","author":"Salama","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2016.07.027_bib26","doi-asserted-by":"crossref","first-page":"6236s","DOI":"10.1158\/1078-0432.CCR-06-0988","article-title":"The measurement of pain from metastatic bone disease: Capturing the patient's experience","volume":"12","author":"Cleeland","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2016.07.027_bib27","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/jncimonographs\/lgm005","article-title":"Symptom burden: Multiple symptoms and their impact as patient-reported outcomes","author":"Cleeland","year":"2007","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.ijrobp.2016.07.027_bib28","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/cncr.28515","article-title":"Stereotactic body radiotherapy: A critical review for nonradiation oncologists","volume":"120","author":"Kirkpatrick","year":"2014","journal-title":"Cancer"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301616329066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301616329066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T00:22:37Z","timestamp":1536538957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301616329066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0360301616329066"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2016.07.027","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-Dose Hypofractionated Radiation Therapy for Noncompressive Vertebral Metastases in Combination With Zoledronate: A Phase 1 Study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2016.07.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}